NOTA analogue: A first dithiocarbamate inhibitor of metallo-beta-lactamases
NOTA analogue: A first dithiocarbamate inhibitor of metallo-beta-lactamases
复制标题
NOTA 类似物:第一个金属-β-内酰胺酶二硫代氨基甲酸盐抑制剂
DOI:
10.1016/j.bmcl.2017.10.074
复制
发表时间:
2018
影响因子:
2.7
通讯作者:
Qin Shangshang
中科院分区:
文献类型:
--
作者:
Zhang En;Wang Ming-Ming;Huang Shu-Chao;Xu Shuai-Min;Cui De-Yun;Bo Yuan-Li;Bai Peng-Yan;Hua Yong-Gang;Xiao Chun-Ling;Qin Shangshang
The emergence of antibiotic drug (like carbapenem) resistance is being a global crisis. Among those resistance factors of the β-lactam antibiotics, the metallo-β-lactamases (MBLs) is one of the most important reasons. In this paper, a series of cyclic dithiocarbamate compounds were synthesized and their inhibition activities against MBLs were initially tested combined with meropenem (MEM) by in vitro antibacterial efficacy tests. Sodium 1,4,7-triazonane-1,4,7-tris(carboxylodithioate) (compound5) was identified as the most active molecule to restore the activity of MEM. Further anti-bacterial effectiveness assessment, compound5restored the activity of MEM againstEscherichia coli, Citrobacter freundii, Proteus mirabilis and Klebsiella pneumonia, which carried resistance genes ofblaNDM-1. The compound5was non-hemolytic, even at a concentration of 1000 µg/mL. This compound was low toxic toward mammalian cells, which was confirmed by fluorescence microscopy image and the inhibition rate of HeLa cells. TheKivalue of compounds5against NDM-1 MBL was 5.63 ± 1.27 μM. Zinc ion sensitivity experiments showed that the inhibitory effect of compound5as a MBLs inhibitor was influenced by zinc ion. The results of the bactericidal kinetics displayed that compound5as an adjuvant assisted MEM to kill all bacteria. These data validated that this NOTA dithiocarbamate analogue is a good inhibitor of MBLs.